Company: IMCR
Filing Date: 2025-03-17
Form Type: 424B7
Source: 0001140361-25-008917
Chunk: 80

Company: Immunocore Holdings plc
Filing Date: 2025-03-17
Form: 424B7
Chunk 80
---
urchase their notes. |

S-44

TABLE OF CONTENTS

Simultaneously with providing such notice, we will publish the information on our website or through such other public medium as we may use at that time. Notwithstanding the foregoing, we will not be required to repurchase, or to make an offer to repurchase, the notes upon a fundamental change if a third party makes such an offer in the same manner, at the same time and otherwise in compliance with the requirements for an offer made by us as set forth above and such third party purchases all notes properly surrendered and not validly withdrawn under its offer in the same manner, at the same time and otherwise in compliance with the requirements for an offer made by us as set forth above. Notwithstanding anything to the contrary, we will not be required to send a fundamental change notice, or offer to repurchase or repurchase any notes, as described above, in connection with a fundamental change occurring pursuant to clause (2)(A) or (B) (or pursuant to clause (1) that also constitutes a fundamental change occurring pursuant to clause (2)(A) or (B)) of the definition thereof, if:

| • | such fundamental change constitutes a share exchange event referred to under the caption “—Conversion Rights—Recapitalizations, Reclassifications and Changes of Our Ordinary Shares,” whose reference property consists entirely of cash in U.S. dollars; |

| • | immediately after such fundamental change, the notes become immediately convertible (pursuant to the provisions described above under the captions “—Conversion Rights—Recapitalizations, Reclassifications and Changes of Our Ordinary Shares” and, if applicable, “—Conversion Rights—Increase in Conversion Rate upon Conversion upon a Make-Whole Fundamental Change, Notice of Optional Redemption or Notice of Tax Redemption”) into consideration that consists solely of U.S. dollars in an amount per $1,000 principal amount of notes that equals or exceeds the fundamental change repurchase price per $1,000 principal amount of notes (calculated assuming that the same includes the maximum amount of accrued but unpaid interest payable as part of the fundamental change repurchase price for such fundamental change); and |

| • | we provide written notice to holders of the effective date of any such transaction as promptly as practicable following the date we publicly announce such transaction or, if practicable to do so using commercially reasonable efforts, prior to such effective date. |

We refer to any fundamental change with respect to which, in accordance with the provisions described above, we